Home » Archive

News

News, Syndication, Xconomy »

Biotech Can’t Sidestep Cost-Effectiveness Anymore

Posted by sandiegobiotech April 2nd, 2012 .
No Comments

Back in the old days of biotech, the business was pretty straightforward. You’d craft your scientific idea, aim a new drug at patients in need, charm investors to give you some money, run bang-up…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

Medistem Appoints Director of Chinese Operations

Posted by Mary Canady March 29th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 29, 2012) – Medistem Inc. (PINKSHEETS: MEDS) announced today the appointment of Feng Lin, MD, Ph.D as Director of Chinese Operations. Dr. Lin has an extensive background in basic research and therapeutics development…

More...

News, Syndication, Xconomy »

Roche Raises Illumina Takeover Bid to $51/Share

Posted by sandiegobiotech March 29th, 2012 .
No Comments

Roche has raised the stakes in its ongoing hostile takeover bid for San Diego-based Illumina (NASDAQ: ILMN) The Switzerland-based healthcare giant said it has raised its offer to $51 a share for…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Amylin Booms on Report it Rejected Bristol’s $3.5B Takeover Bid

Posted by sandiegobiotech March 28th, 2012 .
No Comments

San Diego-based Amylin Pharmaceuticals (NASDAQ: AMLN) saw its shares boom today after it reportedly turned down a $3.5 billion takeover bid from New York-based Bristol-Myers Squibb (NYSE: BMY)….

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

Mentor Capital to Discuss Major Cancer Funding, Low PE and Warrant Call at April 29 Shareholder Meeting

Posted by Mary Canady March 28th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 28, 2012) – Mentor Capital, Inc. (PINKSHEETS: MNTR) will hold its annual shareholders’ meeting at the company offices outside of San Diego, April 29, 2012 at 10:00AM. A management report and director ballots are being…

More...

Marketwire, News, Syndication »

Quidel Receives CE Mark for Its AmpliVue(TM) Hand-Held Molecular Diagnostic Test for Clostridium Difficile

Posted by Mary Canady March 27th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 27, 2012) – Quidel Corporation (NASDAQ: QDEL), announced today that it received CE mark for the AmpliVue C. difficile assay, its non-instrumented molecular test for the detection of toxigenic Clostridium difficile ba…

More...

Marketwire, News, Syndication »

Senomyx to Webcast Corporate Presentation at the 11th Annual Needham Healthcare Conference

Posted by Mary Canady March 27th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 27, 2012) – Senomyx, Inc. (NASDAQ: SNMX), a company using proprietary taste science technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced to…

More...

News, Syndication, Xconomy »

San Diego Tech Roundup: Flud, Verve, and a “Swiss Cheese” Job Market

Posted by sandiegobiotech March 26th, 2012 .
No Comments

Here’s the important technology news from the past week: —The latest jobless numbers for San Diego County remain unchanged—at 9.3 percent—from January to February, according to data released Friday…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks

Posted by sandiegobiotech March 26th, 2012 .
No Comments

Baseball season starts this week, which means it’s time for me to spend too much time and energy on fantasy baseball. This is a strange little hobby in which millions of people use a combination of…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Glaxo and J&J’s Shrewd Move Will Help the Biotech Ecosystem

Posted by sandiegobiotech March 23rd, 2012 .
No Comments

Index Ventures made news recently when it announced a new €150 million fund to invest in early-stage, life science companies. With many venture firms scaling back or exiting the business entirely,…

[[Click headline to continue reading.]]

More...